Steven E Wilson Selected Research

Inflammation (Inflammations)

1/2019	Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease.
2/2012	Cellular effects after laser in situ keratomileusis flap formation with femtosecond lasers: a review.
2/2012	Short-term cell death and inflammation after intracorneal inlay implantation in rabbits.
10/2009	Effect of femtosecond laser energy level on corneal stromal cell death and inflammation.
5/2008	Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea.
1/2008	LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment.
9/2007	Femtosecond laser and microkeratome corneal flaps: comparison of stromal wound healing and inflammation.
4/2007	Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease.
3/2003	Bilateral marginal sterile infiltrates and diffuse lamellar keratitis after laser in situ keratomileusis.
8/2002	Sporadic diffuse lamellar keratitis (DLK) after LASIK.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven E Wilson Research Topics

Disease

29	Fibrosis (Cirrhosis) 05/2024 - 01/2016
17	Cicatrix (Scar) 04/2024 - 02/2012
13	Myopia 01/2017 - 01/2002
12	Wounds and Injuries (Trauma) 04/2024 - 08/2002
10	Corneal Injuries 01/2022 - 08/2009
10	Inflammation (Inflammations) 01/2019 - 08/2002
8	Keratitis 02/2020 - 08/2002
8	Dry Eye Syndromes (Dry Eye Syndrome) 01/2019 - 12/2003
7	Corneal Opacity 01/2023 - 01/2014
7	Pathologic Dilatation (Ectasia) 01/2019 - 01/2002
5	Infections 04/2024 - 12/2020
5	Necrosis 02/2020 - 01/2002
4	Burns 01/2023 - 01/2022
4	Hyperopia (Hypermetropia) 01/2017 - 08/2002
3	Glaucoma 01/2023 - 11/2013
3	Keratoconus 08/2014 - 01/2002
2	Corneal Diseases (Corneal Disease) 01/2022 - 09/2005
2	Astigmatism 03/2017 - 01/2017
2	Refractive Errors (Refractive Error) 07/2012 - 07/2004
1	Chemical Burns (Chemical Burn) 04/2024
1	Lagophthalmos 02/2024
1	Blister (Bulla) 01/2023
1	Hereditary Corneal Dystrophies 01/2023
1	Eye Diseases (Eye Disease) 01/2023
1	Lattice corneal dystrophy type 1 01/2023
1	Blast Injuries 01/2023
1	Neoplasms (Cancer) 09/2022
1	Retrograde Degeneration 12/2018
1	Cataract (Cataracts) 01/2017
1	Photophobia (Light Sensitivity) 01/2016

Drug/Important Bio-Agent (IBA)

10	Transforming Growth Factor beta (TGF-beta)IBA 05/2024 - 05/2006
10	Losartan (Cozaar)FDA LinkGeneric 04/2024 - 01/2022
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2022 - 12/2014
6	CytokinesIBA 12/2020 - 12/2014
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2007
5	CollagenIBA 02/2022 - 06/2012
4	AlkaliesIBA 01/2023 - 01/2022
4	Collagen Type IV (Type IV Collagen)IBA 01/2022 - 12/2021
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2021
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2022 - 01/2022
3	perlecanIBA 02/2022 - 01/2021
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2020
3	Interleukin-1 (Interleukin 1)IBA 01/2021 - 08/2009
3	ChemokinesIBA 12/2020 - 12/2014
2	Lubricant Eye Drops (Artificial Tears)IBA 02/2024 - 01/2008
2	Sodium Hydroxide (Caustic Soda)FDA Link 01/2023 - 01/2022
2	InterleukinsIBA 01/2021 - 01/2020
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2020 - 03/2017
2	EndotoxinsIBA 02/2020 - 08/2002
2	SolutionsIBA 01/2014 - 05/2009
2	VimentinIBA 10/2009 - 08/2009
2	DesminIBA 10/2009 - 08/2009
1	Nerve Growth Factor (NGF)IBA 02/2024
1	Mutant Proteins (Protein, Mutant)IBA 01/2023
1	MetalsIBA 01/2023
1	K-115IBA 09/2022
1	rho-Associated KinasesIBA 09/2022
1	Tyrosine Kinase InhibitorsIBA 09/2022
1	Axitinib (AG 013736)IBA 09/2022
1	Sunitinib (Sutent)FDA Link 09/2022
1	netarsudilIBA 09/2022
1	prednisolone acetate FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Collagenases (Collagenase)FDA Link 12/2020
1	Metalloproteases (Metalloproteinases)IBA 12/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2020
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Collagen Type III (Type III Collagen)IBA 01/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2020
1	Platelet-Derived Growth FactorIBA 01/2020
1	Ophthalmic Solutions (Eye Drops)IBA 01/2019
1	Green Fluorescent ProteinsIBA 01/2018
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Proteoglycans (Proteoglycan)IBA 01/2016
1	Crystallins (Crystallin)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 07/2014
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2014
1	isopropyl 5,12- hydroxypentadeca- 8,10- dien- 6,14- diynoateIBA 01/2014

Therapy/Procedure

24	Laser In Situ Keratomileusis (LASIK) 05/2024 - 01/2002
12	Photorefractive Keratectomy 10/2023 - 01/2002
11	Lasers (Laser) 02/2020 - 07/2004
4	Therapeutics 01/2023 - 01/2007
4	Excimer Lasers 12/2018 - 05/2006
3	Refractive Surgical Procedures 05/2024 - 01/2002
3	Keratectomy 01/2023 - 03/2017
2	Operative Surgical Procedures 01/2023 - 02/2020
2	Penetrating Keratoplasty 01/2020 - 08/2019
1	Contact Lenses 02/2024
1	Bandages (Bandage) 02/2024
1	Duration of Therapy 01/2022
1	Corneal Transplantation (Keratoplasty) 08/2019
1	Debridement 03/2017
1	Slit Lamp 01/2017